- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 395.31M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 397.56M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 386.27M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $21.23M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $16.87M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $3.91B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $4.1B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $643.58M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $791.56M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$1.03B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$1.04B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$1.56B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$1.6B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.23B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.21B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.13B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.3B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.33B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.5B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.09 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $134.01M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $129.95M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $115.92M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $91.4M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $334.98M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $305.47M |
| Revenue | Q1 2026 · Mar 31, 2026 | $760.33M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $702.13M |